The Myelodysplastic Syndromes Channel on VJHemOnc is an independent medical education platform, supported with funding from Geron (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
SOHO 2025 | The growing role of AI in MDS: digital twins, machine learning tools, and more
David Swoboda, MD, Tampa General Hospital Cancer Center, Tampa, FL, discusses the growing use of artificial intelligence (AI) in myelodysplastic syndromes (MDS), highlighting ongoing research that explores the use of digital twins. Dr Swoboda also shares insights into the potential incorporation of machine learning tools to improve MDS prognostication. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
